Prepare
for
Treatment

HOW IS LARTRUVO GIVEN?

Your treatment will be scheduled in cycles. There are 3 weeks (21 days) in each treatment cycle. You will be given treatment on Days 1 and 8 of each 3-week (21-day) cycle.

On the 1st day of treatment, you will receive both LARTRUVO and doxorubicin.

On the 8th day, you will receive LARTRUVO only.

Your doctor will start you on treatment with LARTRUVO and doxorubicin, and may adjust the medicines in your treatment plan over time.

Dosing schedule

On Day 1 of each treatment cycle, you will receive 1 hour of LARTRUVO followed by 1 hour or less of doxorubicin.

You will receive medications before your LARTRUVO infusion. This will help prepare your body for treatment with LARTRUVO.

Your treatment plan may include LARTRUVO and doxorubicin for up to 8 cycles of treatment. After the 8th cycle, your healthcare team may decide to continue treatment with LARTRUVO alone. This will depend on the progress of your disease and how your body responds to therapy.

If your disease progresses at any point during treatment, your doctor will end treatment with LARTRUVO and discuss with you the appropriate next steps for your treatment plan.

HOW LONG WILL EACH VISIT TAKE?

LARTRUVO is given by intravenous (IV) infusion in a doctor’s office, hospital, or infusion center.

You may be at the infusion center for a total of 2 to 3 hours.

Your first infusion will be slightly longer than the rest.

  • For your first infusion, your nurse will give you 2 medications before administering LARTRUVO and doxorubicin. These will help prepare your body for treatment

    • Diphenhydramine (dī-ˌfen-ˈhī-drə-ˌmēn): an antihistamine also known as Benadryl®

    • Dexamethasone (dek-se-ˈmə-thə-sōn): a steroid that helps to treat inflammation, nausea, and vomiting

Beginning with Cycle 5, you may be given a medicine called dexrazoxane, which helps prevent cardiac side effects associated with doxorubicin.

Benadryl® is a registered trademark of Johnson & Johnson.

UNDERSTANDING YOUR INFUSION SETTING

Treatment with LARTRUVO + doxorubicin is most likely to happen at an infusion center or cancer center in a hospital.

  • Infusion Center

    An infusion center can have private rooms or an open floor layout, so you may be in the room with other people who are also receiving treatment. Many infusion centers with open floors have curtains for privacy.

  • Infusion Chair

    You will receive treatment in a specially designed infusion chair that allows the nurse to easily connect you to an IV line. Because infusions can take a few hours, the chair is designed to be comfortable, and usually reclines so you can relax.

  • Treatment Team

    You will encounter several people during your infusion. This includes a nurse who specializes in giving cancer treatment, the staff who are there to sign you in and assist you, and a doctor. This may be your doctor or a different doctor who works at the center.

Your doctor may recommend getting a port. A port (or catheter) is a long plastic tube that connects to a vein and makes receiving longer-term treatment easier for some people. Your doctor can help you determine if a port is right for you.

YOUR FIRST TREATMENT

It’s time for your first LARTRUVO + doxorubicin treatment. You’ve got this.

The tips below are designed to help you get started.

Remember, everyone is different, and many people will want to give you advice. But it’s important to find what works best for you—your preferences, your needs, and your comfort.

BEFORE TREATMENT DAY

  • Plan rides

    There’s no way to predict exactly how your body will react to different medications, so it’s a good idea to arrange for someone to drive you to and from your infusion, at least the first time.

    If you can, familiarize yourself with the location of your infusion site, where to park, and where to sign in upon arrival.

  • Plan a comfortable outfit

    Dress comfortably in soft, loose clothes. For extra comfort, bring your favorite pair of socks and slippers.

  • Plan meals

    It is important to maintain proper nutrition and to stay hydrated. It is also important to minimize stress on your infusion days—planning healthy meals in advance can help both causes.

TIP: Don’t eat 1 to 2 hours before treatment. Avoid eating favorite foods when feeling nauseated as this may diminish your enjoyment of these foods later. A bad experience could turn your most favorites into your least favorites!

IT’S TREATMENT DAY

Bring Your 4 B’s!

A Buddy

A loved one can make
all the difference

A family member or friend can be a great distraction and can provide emotional support. They can also help take notes and organize information, such as post-treatment instructions.

Confirm in advance that your treatment location allows visitors to stay with you during treatment.

A Binder

Be a one-binder wonder!

On the day of your first infusion, the last thing you want to do is go searching for paperwork.

Put all your important documents in one travel binder, with backup copies at home, just in case you need them:

  • Insurance information

  • Paperwork from your doctor such as lab results or prescriptions

  • Contact information for your extended healthcare team and caregivers

  • Appointment schedule

A Bag

Your personal bag of
tricks can save the day

Snacks

  • Ask your doctor or nurse if you can have a snack or drink during your treatment

  • If so, choose snacks that are high in nutritional value, don’t have a strong smell, and are somewhat bland in taste

    • Nuts, whole grain crackers, hard cheese, hummus, granola bars, and fruit

Hard candy

  • During treatment, some people like to suck on hard candy, like mints, lemon drops, or citrus candies. This is to help just in case you experience a slight bitter or metallic taste in your mouth during treatment with doxorubicin

Lip balm, lotion, and ice

  • Keep your lips and skin hydrated with scent-free lip balms and hand lotion

  • You can also ask your nurse for ice packs or cooling caps during treatment. Placing them on your head may help reduce hair loss

Entertainment

  • Everyone is different. Some people prefer to nap while receiving treatment, others like to entertain themselves. Here are a few travel-friendly suggestions to help pass the time:

    • Get lost in a great book—an old favorite or a new adventure, the choice is yours

    • Many people like to relax and listen to music. Make a playlist of your favorite songs that help you achieve the mood you want, relaxation, empowerment, joy—let the music inspire you

    • Lightweight devices such as tablets and phones are great ways to check in on social media, watch movies, or surf the web

    • Are you the crafting type? Bring it along!

A Blanket

Comfort and coziness
are everything

  • Bring a blanket. Treatment areas tend to be cold, so if you don’t have a travel-size blanket, treat yourself to an extra cozy one. You deserve it

  • Keep in mind, you’ll be connected to your IV, which makes removing and adding layers of clothes difficult. So a blanket is best

THE FIRST 24 HOURS AFTER YOUR INFUSION

GOING HOME

You may feel hopeful, relieved, overwhelmed, or just tired. You may experience any range of emotions, but you won’t know until you get there.

One thing is for sure: You got up. You did it. You just got a round of treatment under your belt. Be proud. Pat yourself on the back. Today was a major accomplishment.

HERE ARE A FEW THINGS TO KEEP IN MIND DURING YOUR FIRST 24 HOURS AFTER TREATMENT:

Follow instructions

Once you’re home, it is important to follow any instructions you received. Take your medication on time, rest, hydrate, and eat.

You can ask your buddy to help make sure you’ve picked up any medication you’ll need before returning home.

Keep a journal

It can be really helpful to keep a journal. You can use it to keep track of side effects, including their severity and how long they last. You can also keep a list of questions to ask your doctor at your next visit (which you can then add to your binder).

It can also be helpful to use your journal as an emotional outlet, a place to express your emotions—your hopes, fears, or frustrations. You can also keep track of memorable moments or experiences so they can remain fresh in your mind.

Speak up!

Your doctor is there to help, so don’t hesitate to call.
If you develop any side effects, call your doctor.

Reflect on your first infusion

Reflect on what worked in your first appointment. What went well? What could be improved the next time?

    • Did you forget anything?

    • How was your snack?

    • Did you receive the support you needed from your buddy?

    • Did you receive adequate information about treatment, additional medications, and post-infusion instructions from your nurse?

INDICATION AND IMPORTANT SAFETY INFORMATION

EXPAND

WHO IS LARTRUVO FOR?

LARTRUVO (olaratumab) is a prescription medicine used with a type of chemotherapy called doxorubicin to treat adult patients with soft tissue sarcoma (STS) for whom doxorubicin is appropriate and who cannot be cured with radiation or surgery.

There is an ongoing study to confirm how LARTRUVO works in combination with doxorubicin.

IMPORTANT SAFETY INFORMATION FOR LARTRUVO

What is the most important information I should know about LARTRUVO?

  • Infusion reactions related to injecting LARTRUVO have occurred. Most of these reactions happened during or after the first or second LARTRUVO infusion. Signs and symptoms of infusion reactions include flushing, shortness of breath, severe trouble breathing, or fever/chills. In severe cases, severe low blood pressure, anaphylactic shock (a severe, potentially life-threatening allergic reaction), or cardiac arrest (abrupt loss of heart function) may occur. Tell your doctor if you have any of these symptoms. Your healthcare team will monitor you for these side effects. In the case of a severe infusion reaction, your LARTRUVO treatment will have to be immediately and permanently stopped.

  • LARTRUVO can harm your unborn baby. You should avoid getting pregnant, and use effective birth control while receiving LARTRUVO and for at least 3 months after stopping LARTRUVO.

What are the most common side effects of LARTRUVO?

  • The most common side effects reported in patients treated with LARTRUVO when given in combination with doxorubicin were nausea; tiredness or weakness; pain in the muscles, joints, and bones; sores and swelling of the mouth and digestive tract; hair loss; vomiting; diarrhea; decreased appetite; stomach pain; weakness, numbness, or pain in the hands and feet; and headache.

  • The most common changes to blood tests were low white blood cell count, low platelet count, high blood sugar, increased blood clotting time, low blood potassium level, and low blood phosphate level.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/safety/medwatch or call 1-800-FDA-1088.

What should I tell my doctor before receiving treatment with LARTRUVO?

Before you receive LARTRUVO, tell your doctor if you:

  • Are pregnant or may be pregnant. If you become pregnant during treatment, discuss this with your doctor.

  • Are breastfeeding: your doctor will tell you not to breastfeed during LARTRUVO treatment and for at least 3 months after stopping LARTRUVO.

Tell your doctor about all the medications you are taking, including prescription and over-the-counter medications.

LARTRUVO is available by prescription only.

Please see full Prescribing Information for additional information about LARTRUVO.

OR CON ISI 12JAN2017

WHO IS LARTRUVO FOR?

LARTRUVO (olaratumab) is a prescription medicine used with a type of chemotherapy called doxorubicin to treat adult patients with soft tissue sarcoma (STS) for whom doxorubicin is appropriate and who cannot be cured with radiation or surgery.

There is an ongoing study to confirm how LARTRUVO works in combination with doxorubicin.

IMPORTANT SAFETY INFORMATION FOR LARTRUVO

What is the most important information I should know about LARTRUVO?

  • Infusion reactions related to injecting LARTRUVO have occurred. Most of these reactions happened during or after the first or second LARTRUVO infusion. Signs and symptoms of infusion reactions include flushing, shortness of breath, severe trouble breathing, or fever/chills. In severe cases, severe low blood pressure, anaphylactic shock (a severe, potentially life-threatening allergic reaction), or cardiac arrest (abrupt loss of heart function) may occur. Tell your doctor if you have any of these symptoms. Your healthcare team will monitor you for these side effects. In the case of a severe infusion reaction, your LARTRUVO treatment will have to be immediately and permanently stopped.

  • LARTRUVO can harm your unborn baby. You should avoid getting pregnant, and use effective birth control while receiving LARTRUVO and for at least 3 months after stopping LARTRUVO.

What are the most common side effects of LARTRUVO?

  • The most common side effects reported in patients treated with LARTRUVO when given in combination with doxorubicin were nausea; tiredness or weakness; pain in the muscles, joints, and bones; sores and swelling of the mouth and digestive tract; hair loss; vomiting; diarrhea; decreased appetite; stomach pain; weakness, numbness, or pain in the hands and feet; and headache.

  • The most common changes to blood tests were low white blood cell count, low platelet count, high blood sugar, increased blood clotting time, low blood potassium level, and low blood phosphate level.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/safety/medwatch or call 1-800-FDA-1088.

What should I tell my doctor before receiving treatment with LARTRUVO?

Before you receive LARTRUVO, tell your doctor if you:

  • Are pregnant or may be pregnant. If you become pregnant during treatment, discuss this with your doctor.

  • Are breastfeeding: your doctor will tell you not to breastfeed during LARTRUVO treatment and for at least 3 months after stopping LARTRUVO.

Tell your doctor about all the medications you are taking, including prescription and over-the-counter medications.

LARTRUVO is available by prescription only.

Please see full Prescribing Information for additional information about LARTRUVO.

OR CON ISI 12JAN2017

X

You are now leaving the www.LARTRUVO.com website.

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC, does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC, is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

  • Continue

  • Cancel

X

For US Healthcare Professionals

The information contained in www.LARTRUVO.com/hcp is technical in nature and intended for healthcare professionals in the United States only.

I'd like information for:

  • Healthcare Professionals

  • Patients and Caregivers